Article
Prognosis and therapy of chronic lymphocytic leukemia and small lymphocytic lymphoma.
Cancer treatment and research - 1 Jan 2015
Sun Clare, Wiestner Adrian
Abstract excerpt
Chronic lymphocytic leukemia (CLL) is characterized by a highly variable clinical course that has guided treatment principles in as much as anti-leukemic therapy is reserved for patients with active disease. This heterogeneity is somewhat dissected by prognostic markers, many of which represent pathogenic mechanisms. Recently, the introduction of highly active targeted agents and maturing data on predictive...
Topics
Join the communities discussing this publication.